You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API GLYCOPYRROLATE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing GLYCOPYRROLATE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Merz Pharmaceuticals LLC CUVPOSA glycopyrrolate 0259-0501 CITRIC ACID MONOHYDRATE
Merz Pharmaceuticals LLC CUVPOSA glycopyrrolate 0259-0501 GLYCERIN
Merz Pharmaceuticals LLC CUVPOSA glycopyrrolate 0259-0501 METHYLPARABEN
Merz Pharmaceuticals LLC CUVPOSA glycopyrrolate 0259-0501 PROPYLENE GLYCOL
Merz Pharmaceuticals LLC CUVPOSA glycopyrrolate 0259-0501 PROPYLPARABEN
Merz Pharmaceuticals LLC CUVPOSA glycopyrrolate 0259-0501 SACCHARIN SODIUM
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing GLYCOPYRROLATE

Company Ingredient NDC Excipient
West-ward Pharmaceutical Corp glycopyrrolate 0143-1250 ANHYDROUS LACTOSE
West-ward Pharmaceutical Corp glycopyrrolate 0143-1250 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
West-ward Pharmaceutical Corp glycopyrrolate 0143-1250 LACTOSE MONOHYDRATE
West-ward Pharmaceutical Corp glycopyrrolate 0143-1250 MAGNESIUM STEARATE
West-ward Pharmaceutical Corp glycopyrrolate 0143-1250 POVIDONE K30
West-ward Pharmaceutical Corp glycopyrrolate 0143-1250 SODIUM STARCH GLYCOLATE TYPE A POTATO
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for GLYCOPYRROLATE

Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZYL ALCOHOL

Excipient focus: CALCIUM CHLORIDE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

GLYCOPYRROLATE drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Company Ingredient NDC
NCS HealthCare of KY Inc dba Vangard Labs glycopyrrolate 0615-8170
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc glycopyrrolate 23155-606
Par Pharmaceutical Inc glycopyrrolate 49884-065
Chartwell RX LLC glycopyrrolate 62135-734
Bryant Ranch Prepack glycopyrrolate 63629-5442
REMEDYREPACK INC glycopyrrolate 70518-3031
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CALCIUM PYROPHOSPHATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: NORFLURANE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group